2-amino-3-methylimidazo(4,5-f)quinoline and Aberrant Crypt Foci

2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Aberrant Crypt Foci in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukushima, S; Hirose, M; Nakae, D; Takahashi, S; Tatematsu, M; Totsuka, Y; Tsuda, H; Wanibuchi, H; Wei, M	1

Other Studies

1 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Aberrant Crypt Foci

Article	Year
Low-dose carcinogenicity of 2-amino-3-methylimidazo[4,5-f ]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21(Cip / WAF1). Cancer science, 2011, Volume: 102, Issue:1 Topics: Aberrant Crypt Foci; Animals; Carcinogens; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; DNA Adducts; DNA-(Apurinic or Apyrimidinic Site) Lyase; Glutathione S-Transferase pi; Liver; Male; Nuclear Proteins; Quinolines; Rats; Rats, Inbred F344	2011

Article

Year

Low-dose carcinogenicity of 2-amino-3-methylimidazo[4,5-f ]quinoline in rats: Evidence for the existence of no-effect levels and a mechanism involving p21(Cip / WAF1).

Cancer science, 2011, Volume: 102, Issue:1

Topics: Aberrant Crypt Foci; Animals; Carcinogens; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; DNA Adducts; DNA-(Apurinic or Apyrimidinic Site) Lyase; Glutathione S-Transferase pi; Liver; Male; Nuclear Proteins; Quinolines; Rats; Rats, Inbred F344

2011